CXC-AG
CXC-AG is a division of CXC, solely focused on developing and commercializing research from top university laboratories. CXC-AG has strong links to McGill University, especially the Smith Lab which is renowned for developing lipochito-oligosaccharides (LCOs), which are arguably the biggest hit in biologicals, in use on hundreds of millions of acres worldwide.
Biologicals
BioFuelNet Canada Inks Research Deal with CXC-AG for 450 Bacterial Strains to Fight GHGs
The new strains have the potential to increase yields in the absence of abiotic stress.
Latest News
AgriBusiness Global Report
Neil DeStefano on How Biologicals Companies Can Achieve Success in the U.S.
In this AgriBusiness Global Report, Neil DeStefano, Principal of...
ABG Update Feature
Beyond Tariffs: The Bigger Trends Emerging from SACA 2026
Nearly 2,000 attendees gathered to discuss market outlooks, sourcing...
Industry News
Seed Industry Applauds EU Approval of New Genomic Techniques Regulation
The legislation establishes a modern, science-based regulatory framework for...
Herbicides
FMC Corp. and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology
This collaboration will enable more growers across the Americas...